Luo Wen
Chairman and General Manager
biotechnology
Denovo Biopharma
China
Biography
Company co-founder and the main technology inventor. Has 20 years of experience in biomedical research and industry, specializing in bioinformatics, human genomics applied to drug research and development, clinical biomarkers and personalized treatment, former American Ligand Pharma clinical biomarkers and biological genome executives, previously He is a senior bioinformatics researcher at Incyte Genomics, the largest gene company in the United States. Dr. Rowan is also working on the development and identification of innovative drug targets in the field of cancer, immune diseases, and angiogenesis, the well-known protein kinase company Sugen, which has been acquired by Pfizer. Rowan has published more than ten papers in world-class bioscience journals, and is the inventor of several global gene patents. He studied at the Peking Union Medical College in Beijing with a Ph.D. in Biochemistry from the University of Indiana and completed his postdoctoral studies at the Howard University Medical Center (HHMI) at the University of California San Francisco Medical School (UCSF).
Research Interest
bioinformatics
